Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03830840
Other study ID # 2017 - 6004
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 1, 2019
Est. completion date March 29, 2022

Study information

Verified date June 2022
Source Sansum Diabetes Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The Mil Familias Cohort Establishment involves enrolling 1000 Latino families with at least one member in the family having type 2 diabetes, including children and youth, and measuring the 5 determinants of human health: genetics, biology, behavior, psychology, and society/environment.


Description:

The vision of Mil Familias is to reduce the burden of cardio-metabolic disease among Latino families in Santa Barbara County and beyond. The aim is to establish an observational cohort of 1,000 Latino families, with at least one family member currently living with diabetes, in order to understand better the impact of the 5 determinants of human health (genetics, biology, behavior, psychology, and society/environment) in this population. Once the 1,000-family cohort is established, evidence-based intervention studies will be developed and implemented based on new knowledge, with collaborators from the healthcare, public policy, academic, pharmaceutical, medical device and technology industries. The strategy involves 4 coordinated and iterative components to achieve its mission: 1. Especialistas: Trusted, bilingual community health workers specially-trained in diabetes education, clinical research methodologies, and care referral. The Especialistas will engage directly with participants to conduct research activities, answer questions, and when necessary, refer participants to appropriate, local community resources. 2. Data: Facilitated by Especialistas, each individual participant will contribute information on up to 100 different variables relating to their genetics, biology, psychology, behavior and society/environment, thus creating a one-of-a-kind database and associated specimen biobank on Latino health and lifestyle ("Living Information Bank"). 3. Interventions: Based on the data, evidence-based, collaborative, culturally-relevant prevention and treatment strategies are planned to develop once the cohort of 1,000 families has been established. 4. Allies: This community-based participatory research study requires engagement from key stakeholders from the Latino community, healthcare sectors, hospitals, payers, businesses, people with diabetes and philanthropists. Organizations and individuals support Mil Familias by contributing their resources, experiences, and skill-sets.


Recruitment information / eligibility

Status Completed
Enrollment 405
Est. completion date March 29, 2022
Est. primary completion date March 29, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 7 Years and older
Eligibility Inclusion Criteria: 1. Males or females = 7 years of age at enrollment. 2. Self-reported Latino heritage. 3. Co-resides with immediate family member (as defined above) OR self with established diagnosis of Type 2 Diabetes for at least one year prior to enrollment date. 4. Signed and dated written informed consent by the date of enrollment. 5. Based on the research staff's judgment, subject or subject's representative must have a good understanding, ability, and willingness to adhere to the protocol, including performance of self-monitored data collection during the wearable device portion. - Exclusion Criteria: 1. Life expectancy < 6 months. 2. Any active clinically significant physical or mental disease or disorder, which in the investigator's opinion could interfere with the participation of the trial. 3. Language barriers precluding comprehension of study activities and informed consent. 4. Participation in other trials involving medication or device within 1 month prior to enrollment. 5. Known or suspected abuse of alcohol, narcotics, or illicit drugs. -

Study Design


Locations

Country Name City State
United States Sansum Diabetes Research Institute Santa Barbara California

Sponsors (2)

Lead Sponsor Collaborator
Sansum Diabetes Research Institute Eli Lilly and Company

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Physical activity measured by two wearable physical activity monitors for 1 week Participants wear an ActiGraph and Fitbit activity monitors simultaneously for 1 week, complete an activity log, and answer a user experience questionnaire. On-going activity encounter up to twice in 1 year
Primary Success (evaluated by Yes/No format) recruiting and establishing an observational cohort of 1,000 Latino families with at least one family member living with type 2 diabetes by deploying the methods proven feasible by Mil Familias Operational Pilot. The Mil Familias Cohort Establishment will expand upon the Mil Familias Operational Pilot cohort and infrastructure to collect and store the up to 100 proposed variables across the 5 determinants of human health to support long-term Mil Familias implementation. The variables pertaining to each participant will be collected and stored at the initial visit and then annually for up to 3 years. Socio-demographic characteristics of the cohort will be described at enrollment by type 2 diabetes status, including age, gender, self-identified race/ethnicity, number of people in household, education, insurance, income, occupation, HbA1c, and country of birth. 3 years
Secondary Socio-demographics assessed by questionnaire. Socio-demographics measured by questionnaire - including age, gender, self-identified race/ethnicity, contact information, number in household, income, education, marital status, occupation, caring for elder, night shifts, insurance status, insurance type and payer, influenza immunization status, immigration status, alcohol & tobacco use, birth place,and duration of time in the United States (<5 years, 5-9 years, 10-14 years, 15-19 years, 20-24 years, =25 years). Introductory interview/ demographics/ contacts and annually up to 3 years
Secondary Number of healthcare visits and the difficulty in traveling to the healthcare provider assessed by questionnaire Number of visits to a healthcare provider in the last year and difficulty in traveling to a healthcare provider measured by interview questionnaire Introductory interview/ demographics/ contacts and annually up to 3 years
Secondary Questions regarding personal opinions regarding the burden of diabetes on Latinos measured by specific questions Personal opinion regarding type 2 diabetes burden on Latinos measured by 3 questions - why is diabetes common in Latinos, what can be done to prevent diabetes in Latinos, and what things make it difficult to get help with diabetes when it is needed? Introductory interview/ demographics/ contacts and annually up to 3 years
Secondary Total daily tortilla consumption The number of flour and/or corn tortillas consumed daily for the past 30 days is estimated Introductory interview/ demographics/ contacts and annually up to 3 years
Secondary Daily sugary drink consumption Daily sugary drink consumption is measured by the 2 questions in the Sugar Sweetened Beverages module of the Behavioral Risk Factor Surveillance System Questionnaire from the Centers for Disease Control. Introductory interview/ demographics/ contacts and annually up to 3 years
Secondary Number of times per week eating meals prepared away from home NHANES 2017-2018 question asked - During the past 7 days, how many meals did you get that were prepared away from home in places such as restaurants, fast food places, food stands, grocery stores, or from vending machines? Introductory interview/ demographics/ contacts and annually up to 3 years
Secondary Laboratory blood draw for evaluation of C-Peptide related to diabetes C-Peptide, ng/mL, will measured in a laboratory blood draw sample. Laboratory encounter and annually up to 3 years
Secondary Laboratory blood draw for evaluation of C-Reactive protein related to diabetes C-Reactive protein, mg/L, will measured in a laboratory blood draw sample. Laboratory encounter and annually up to 3 years
Secondary Laboratory blood draw for evaluation of Complete Blood Count Complete Blood Count will measured in a laboratory blood draw sample. Laboratory encounter and annually up to 3 years
Secondary Laboratory blood draw for evaluation of Comprehensive Metabolic Panel Comprehensive Metabolic Panel will measured in a laboratory blood draw sample. Laboratory encounter and annually up to 3 years
Secondary Laboratory blood draw for evaluation of Glutamic Acid Decarboxylase (GAD) antibodies related to diabetes Glutamic Acid Decarboxylase (GAD) antibodies, U/mL, will measured in a laboratory blood draw sample. Laboratory encounter and annually up to 3 years
Secondary Laboratory blood draw for evaluation of HbA1c related to diabetes HbA1c % will measured in a laboratory blood draw sample. Laboratory encounter and annually up to 3 years
Secondary Laboratory blood draw for evaluation of Insulin autoantibody related to diabetes Insulin autoantibody, U/mL, will measured in a laboratory blood draw sample. Laboratory encounter and annually up to 3 years
Secondary Laboratory blood draw for evaluation of Islet antigen 2 (IA-2) antibody related to diabetes Islet antigen 2 (IA-2) antibody, U/mL, will measured in a laboratory blood draw sample. Laboratory encounter and annually up to 3 years
Secondary Laboratory blood draw for evaluation of lipids Lipids will measured in a laboratory blood draw sample. Laboratory encounter and annually up to 3 years
Secondary Laboratory blood draw for evaluation of Insulin Insulin, milliunits/L, will measured in a laboratory blood draw sample. Laboratory encounter and annually up to 3 years
Secondary Laboratory blood draw for evaluation of thyroid function Thyroid function will measured in a laboratory blood draw sample. Laboratory encounter and annually up to 3 years
Secondary Microalbumin measured in a urine sample Urine sample collected for measuring microalbumin mg/L Laboratory encounter and annually up to 3 years
Secondary Creatinine measured in a urine sample Urine sample collected for measuring creatinine Laboratory encounter and annually up to 3 years
Secondary Microalbumin/creatinine ratio measured in a urine sample Urine sample collected for measuring the microalbumin/creatinine ratio Laboratory encounter and annually up to 3 years
Secondary Cheek cells and saliva for genomic analysis Cheek epithelial cells from a swab and saliva samples will be collected for genetic analysis Laboratory encounter and annually up to 3 years
Secondary Stool samples for microbiome analysis Stool/fecal samples will be collected for microbiome analysis Laboratory encounter and annually up to 3 years
Secondary Height measured by Physical exam Height measured in centimeters or inches by physical exam Physical exam encounter and annually up to 3 years
Secondary Weight measured by Physical exam Weight measured in kilograms or pounds by physical exam Physical exam encounter and annually up to 3 years
Secondary Waist circumference measured by Physical exam Waist circumference measured in centimeters or inches by physical exam Physical exam encounter and annually up to 3 years
Secondary Blood pressure measured by Physical exam Blood pressure, systolic and diastolic, measured in mmHg by physical exam Physical exam encounter and annually up to 3 years
Secondary Temperature measured by Physical exam Temperature measured in degrees by physical exam Physical exam encounter and annually up to 3 years
Secondary Heart rate measured by Physical exam Heart rate measured in beats per minute by physical exam Physical exam encounter and annually up to 3 years
Secondary Foot examination evaluated by Questions and Physical exam Foot examination with yes or no questions and by physical exam Physical exam encounter and annually up to 3 years
Secondary Neuropathy Questions during Physical exam Questions about neuropathy Physical exam encounter and annually up to 3 years
Secondary Retinopathy questions during Physical exam Questions about retinopathy Physical exam encounter and annually up to 3 years
Secondary Dental exam Questions during Physical exam Questions about dental exams Physical exam encounter and annually up to 3 years
Secondary Eye exam Questions during Physical exam Questions about eye exams Physical exam encounter and annually up to 3 years
Secondary Medical history, family medical history, and medication status and history assessed by interview Medical history including date of diabetes diagnosis, family medical history, and current medications verified by visual inspection and medication history assessed by interview questionnaire Physical exam encounter and annually up to 3 years
Secondary Menopausal status, pregnancy status, and gestational diabetes history for women determined by interview Menopausal status, pregnancy status (number of live births, number of stillbirths, birthweights of live births, and any diagnosis of type 1 diabetes), and gestational diabetes history for female participants will be determined by interview Physical exam encounter and annually up to 3 years
Secondary Determination of diabetes related foot disease Questionnaire for determination of diabetes related foot disease (Q-DFD) Questionnaires encounter and annually up to 3 years
Secondary Acculturation measured by the Brief Acculturation Scale for Hispanics (BASH) BASH is a participant reported questionnaire to measure acculturation. Responses are scored as 1 = only Spanish, 2 = Spanish more than English, 3 = Spanish and English equally, 4 = English more than Spanish, and 5 = only English. Items are summed and divided by the number of items. Low acculturation is less than or equal to 3.0, and high acculturation is greater than or equal to 3.0. Questionnaire encounter and annually up to 3 years
Secondary Quality of life measured by the Short Form Health Survey (SF-12) The SF-12 is a participant reported questionnaire to measure quality of life Questionnaires encounter and annually up to 3 years
Secondary Depression measured by the Patient Health Questionnaire-9 The Patient Health Questionnaire (PHQ)-9 is the Major Depressive Disorder (MDD) module of the full PHQ Questionnaires encounter and annually up to 3 years
Secondary Perceived Ethnic Discrimination measured by the Brief Perceived Ethnic Discrimination Questionnaire - Community version (PEDQ-CV) PEDQ-CV is a participant reported questionnaire to measure perceived ethnic discrimination Questionnaires encounter and annually up to 3 years
Secondary Adverse Childhood Experiences (ACE) quantified by ACE questionnaire Adverse Childhood Experiences (ACEs) refers to a range of events that a child can experience, which lead to stress and can result in trauma and chronic stress responses. An ACE score will be quantified by a specific ACE questionnaire. Questionnaires encounter and annually up to 3 years
Secondary Spirituality measured by a Spiritual Well Being Scale FACIT" (Functional Assessment of Chronic Illness Therapy) Sp-12 is a questionnaire for measuring spiritual well being. Questions are scored from 0 = Not at all to 4 = Very much. Sub-scales are created for meaning, peace, and faith with score ranges of 0 - 16. Adding these 3 scores gives a total score and the range is 0 - 48 with low scores indicating low spiritual well being and high scores indicating higher spiritual well being. Questionnaires encounter and annually up to 3 years
Secondary Risk Perception Survey For Developing Diabetes (RPS-DD) Diabetes risk perception will be measured by the Risk Perception Survey For Developing Diabetes (RPS-DD) Questionnaires encounter and annually up to 3 years
Secondary Sleep quality measured by the Oviedo Sleep Questionnaire (OSQ) The OSQ is a participant reported questionnaire to measure sleep quality Questionnaires encounter and annually up to 3 years
Secondary Stress measured by the 4 item Perceived Stress Scale (PSS) PSS is a participant reported questionnaire to measure stress. The scale ranges from 0 = never to 4 = very often. The final score ranges from 0 - 16, with higher scores indicating more stress. Questionnaires encounter and annually up to 3 years
Secondary Drug abuse measured by the Drug Abuse Screening Test (DAST) - 20 The purpose of the DAST-20 is to provide a brief, simple, practical, but valid method for identifying individuals who are abusing psychoactive drugs; and to yield a quantitative index score of the degree of problems related to drug use and misuse Questionnaires encounter and annually up to 3 years
Secondary Diabetes management measured by the Diabetes Symptom Self-Care Inventory Ability to manage diabetes self-care assessed by the Diabetes Symptom Self-Care Inventory (DSSCI) Questionnaires encounter and annually up to 3 years
Secondary Family diabetes management measured by questionnaire Family diabetes Self-Efficacy for management of diabetes measured by questionnaire (FSE) Questionnaires encounter and annually up to 3 years
Secondary Foot self care confidence measured by questionnaire Foot Care Confidence Scale (FCCS) is an instrument designed to measure the confidence (self-efficacy) of individuals with type 2 diabetes to perform foot self care Questionnaires encounter and annually up to 3 years
Secondary Health literacy measured by the Short Assessment of Health Literacy (SAHL) SAHL is a participant reported questionnaire to measure health literacy Questionnaires encounter and annually up to 3 years
Secondary Measurement of health numeracy Newest Vital Sign (NVS) is a tool to assess health literacy and numeracy in English and Spanish Questionnaires encounter and annually up to 3 years
Secondary Trust in physician measured by the Trust in Physician (TPS) questionnaire The TPS is a questionnaire and scale to determine trust in the physician Questionnaires encounter and annually up to 3 years
Secondary Social needs screening assessed by the Health Leads Screening toolkit The Health Leads Screening tookit (Boston, MA) will be used to determine social needs - housing instability, childcare, utility needs, financial resource strain, transportation, and exposure to violence. Questionnaires encounter and annually up to 3 years
Secondary Food security assessed by U.S. Household Food Security Survey Module: Six-item short form Food security or insecurity assessed by a six-item short form developed by the Economic Research Service, United States Department of Agriculture (USDA), September 2012 Questionnaires encounter and annually up to 3 years
Secondary Functional support measured by the SSQ6 Social Support Questionnaire - Short Form (SSQ6) measures functional social support Questionnaires encounter and annually up to 3 years
Secondary Support structure measured by Medical Outcomes Study Social Support Survey (mMOS-SS) The eight-item modified Medical Outcomes Study Social Support Survey (mMOS-SS) measures support structure by counting the number of people supporting and satisfaction with that support Questionnaires encounter and annually up to 3 years
Secondary National survey of children's health (NSCH) for all children and youth The NSCH, a validated survey of children's health and translated into Spanish, will assess health of children and youth Questionnaires encounter and annually up to 3 years
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06211361 - Cardiac Rehabilitation Program in Patients With Cardiovascular Disease N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)